Involvement of galanin in nociceptive regulation in the arcuate nucleus of hypothalamus in rats with mononeuropathy

Behavioural Brain Research

Volumn 179, Issue 2, 2007, Pages 331-335

  Gu, Xing Long ^a   Sun, Yan Gang ^a   Yu, Long Chuan ^a  

^a National Laboratory of Biomembrane and Membrane Biotechnology   (China)

Author keywords

Antinociception; Arcuate nucleus; Galanin; Hindpaw withdrawal latency; Mononeuropathy

Indexed keywords

GALANIN; GALANIN RECEPTOR; GALANTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; MALE; MECHANICAL STIMULATION; MONONEUROPATHY; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RAT; THERMAL STIMULATION; WITHDRAWAL REFLEX;

ANIMALS; ARCUATE NUCLEUS; GALANIN; MALE; MONONEUROPATHIES; PAIN THRESHOLD; RATS; RATS, WISTAR; REACTION TIME;

EID: 34047138835     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.02.033     Document Type: Article

References (32)

1. Bartfai T., Lu X., Badie-Mahdavi H., Barr A.M., Mazarati A., Hua X.Y., et al. Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests. Proc Natl Acad Sci USA 101 (2004) 10470-10475
2. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
3. Brewer A., Echevarria D.J., Langel U., and Robinson J.K. Assessment of new functional roles for galanin in the CNS. Neuropeptides 39 (2005) 323-326
4. Colvin L.A., Mark M.A., and Duggan A.W. The effect of a peripheral mononeuropathy on immunoreactive (ir)-galanin release in the spinal cord of the rat. Brain Res 766 (1997) 259-261
5. Flatters S.J., Fox A.J., and Dickenson A.H. In vivo and in vitro effects of peripheral galanin on nociceptive transmission in naive and neuropathic states. Neuroscience 116 (2003) 1005-1012
6. Gundlach A.L., Burazin T.C., and Larm J.A. Distribution, regulation and role of hypothalamic galanin systems: renewed interest in a pleiotropic peptide family. Clin Exp Pharmacol Physiol 28 (2001) 100-105
7. Hobson S.A., Holmes F.E., Kerr N.C., Pope R.J., and Wynick D. Mice deficient for galanin receptor 2 have decreased neurite outgrowth from adult sensory neurons and impaired pain-like behaviour. J Neurochem 99 (2006) 1000-1010
8. Holmes F.E., Mahoney S.A., and Wynick D. Use of genetically engineered transgenic mice to investigate the role of galanin in the peripheral nervous system after injury. Neuropeptides 39 (2005) 191-199
9. Hygge-Blakeman K., Brumovsky P., Hao J.X., Xu X.J., Hokfelt T., Crawley J.N., et al. Galanin over-expression decreases the development of neuropathic pain-like behaviors in mice after partial sciatic nerve injury. Brain Res 1025 (2004) 152-158
10. Imbe H., Abe T., Okamoto K., Sato M., Ito H., Kumabe S., et al. Increase of galanin-like immunoreactivity in rat hypothalamic arcuate neurons after peripheral nerve injury. Neurosci Lett 368 (2004) 102-106
11. Jimenez-Andrade J.M., Zhou S., Yamani A., Valencia d I., Castaneda-Hernandez G., and Carlton S.M. Mechanism by which peripheral galanin increases acute inflammatory pain. Brain Res 1056 (2005) 113-117
12. Li J.J., Zhou X., and Yu L.C. Involvement of neuropeptide Y and Y1 receptor in antinociception in the arcuate nucleus of hypothalamus, an immunohistochemical and pharmacological study in intact rats and rats with inflammation. Pain 118 (2005) 232-242
13. Liu H., and Hokfelt T. Effect of intrathecal galanin and its putative antagonist M35 on pain behavior in a neuropathic pain model. Brain Res 886 (2000) 67-72
14. Liu H.X., and Hokfelt T. The participation of galanin in pain processing at the spinal level. Trends Pharmacol Sci 23 (2002) 468-474
15. Lundstrom L., Elmquist A., Bartfai T., and Langel U. Galanin and its receptors in neurological disorders. Neuromolecular Med 7 (2005) 157-180
16. Ma W., and Bisby M.A. Increase of galanin mRNA in lumbar dorsal root ganglion neurons of adult rats after partial sciatic nerve ligation. Neurosci Lett 262 (1999) 195-198
17. Melander T., Hokfelt T., and Rokaeus A. Distribution of galaninlike immunoreactivity in the rat central nervous system. J Comp Neurol 248 (1986) 475-517
18. Molnar A., Balaspiri L., Galfi M., Laszlo F., Varga C., Berko A., et al. Inhibitory effects of different galanin compounds and fragments on osmotically and histamine-induced enhanced vasopressin secretion in rats. Eur J Pharmacol 516 (2005) 174-179
19. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1998), Academic Press, Sydney
20. Shi T.J., Hua X.Y., Lu X., Malkmus S., Kinney J., Holmberg K., et al. Sensory neuronal phenotype in galanin receptor 2 knockout mice: focus on dorsal root ganglion neurone development and pain behaviour. Eur J Neurosci 23 (2006) 627-636
21. Sun Y.G., Gu X.L., Lundeberg T., and Yu L.C. An antinociceptive role of galanin in the arcuate nucleus of hypothalamus in intact rats and rats with inflammation. Pain 106 (2003) 143-150
22. Sun Y.G., Li J., Yang B.N., and Yu L.C. Antinociceptive effects of galanin in the rat tuberomammillary nucleus and the plasticity of galanin receptor 1 during hyperalgesia. J Neurosci Res 77 (2004) 718-722
23. Walton K.M., Chin J.E., Duplantier A.J., and Mather R.J. Galanin function in the central nervous system. Curr Opin Drug Discov Dev 9 (2006) 560-570
24. Wang D., Lundeberg T., and Yu L.C. Antinociceptive role of galanin in periaqueductal grey of rats with experimentally induced mononeuropathy. Neuroscience 96 (2000) 767-771
25. Wang D., Ye H.H., Yu L.C., and Lundeberg T. Intra-periaqueductal grey injection of galanin increases the nociceptive response latency in rats, an effect reversed by naloxone. Brain Res 834 (1999) 152-154
26. Weiss J.M., Boss-Williams K.A., Moore J.P., Demetrikopoulos M.K., Ritchie J.C., and West C.H. Testing the hypothesis that locus coeruleus hyperactivity produces depression-related changes via galanin. Neuropeptides 39 (2005) 281-287
27. Wiesenfeld-Hallin Z., and Xu X.J. Neuropeptides in neuropathic and inflammatory pain with special emphasis on cholecystokinin and galanin. Eur J Pharmacol 429 (2001) 49-59
28. Wiesenfeld-Hallin Z., Xu X.J., Crawley J.N., and Hokfelt T. Galanin and spinal nociceptive mechanisms: recent results from transgenic and knock-out models. Neuropeptides 39 (2005) 207-210
29. Wilson-Gerwing T.D., and Verge V.M. Neurotrophin-3 attenuates galanin expression in the chronic constriction injury model of neuropathic pain. Neuroscience 141 (2006) 2075-2085
30. Wynick D., and Bacon A. Targeted disruption of galanin: new insights from knock-out studies. Neuropeptides 36 (2002) 132-144
31. Yu L.C., Hansson P., and Lundeberg T. The calcitonin gene-related peptide antagonist CGRP8-37 increases the latency to withdrawal responses bilaterally in rats with unilateral experimental mononeuropathy, an effect reversed by naloxone. Neuroscience 71 (1996) 523-531
32. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110